Connect with us

Technology

In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market Transformation – Technavio

Published

on

NEW YORK, Dec. 3, 2024 /PRNewswire/ — Report with the AI impact on market trends – The global in-vitro and in-vivo micro electrode array market size is estimated to grow by USD 7 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 4.3% during the forecast period. Extensive use of meas in neuroscience research is driving market growth, with a trend towards potential application of in-vitro and in-vivo mea in cancer tissue detection. However, limitations of meas poses a challenge. Key market players include 3Brain AG, Alpha Omega Engineering Ltd., Axion BioSystems Inc., Blackrock Microsystems Inc., Cambridge NeuroTech, FHC Inc., Harvard Bioscience Inc., IMEC Inc., Innovative Neurophysiology Inc., MaxWell Biosystems AG, Microprobes for Life Science, MICRUX FLUIDIC S.L., NeuroNexus Technologies Inc., NMI Technologie Transfer GmbH, Plexon Inc., Ripple Neuro, Screen Holdings Co. Ltd, SpikeGadgets, Tucker Davis Technologies, and World Precision Instruments.

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

In-Vitro And In-Vivo Micro Electrode Array Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.3%

Market growth 2024-2028

USD 7 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

4.0

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 58%

Key countries

US, UK, Germany, France, and Japan

Key companies profiled

3Brain AG, Alpha Omega Engineering Ltd., Axion BioSystems Inc., Blackrock Microsystems Inc., Cambridge NeuroTech, FHC Inc., Harvard Bioscience Inc., IMEC Inc., Innovative Neurophysiology Inc., MaxWell Biosystems AG, Microprobes for Life Science, MICRUX FLUIDIC S.L., NeuroNexus Technologies Inc., NMI Technologie Transfer GmbH, Plexon Inc., Ripple Neuro, Screen Holdings Co. Ltd, SpikeGadgets, Tucker Davis Technologies, and World Precision Instruments

Market Driver

The In-vitro and In-vivo Micro Electrode Array (MEA) market is experiencing significant growth due to increasing research in neurological disorders and cancer tissue detection. MEAs, also known as Micro Electrode Arrays, are essential tools for recording neural activity and measuring brain function. The market includes both Multiwell MEAs and Single well MEAs, with CMOS-based MEAs gaining popularity for their cost-effectiveness and high-density electrodes. Key players in the market include Pharmaceutical and Biotech companies, Contract Research Organizations (CROs), and government research labs. Trends include the development of Neurostimulation devices, Diagnostic Solutions, and Therapeutic Solutions using MEAs. New technologies like 3D nanoparticle printing, Graphene-based Electrodes, and Flexible Electrodes are enhancing MEA capabilities. Neuroengineering applications, such as Brain-Computer Interfaces, Deep Brain Stimulation, and Synaptic Connections, are also driving market growth. Biocompatibility and signal quality remain crucial factors, with advancements in microfabrication techniques like Photolithography and 3D Printing addressing these challenges. The market encompasses applications in Clinical Settings, Drug Development, Disease Modeling, Neuroprosthetics, and Brain-Computer Interfaces. Personalized Medicine and Wireless Recording Technologies are emerging trends, offering opportunities for Drug Candidates and improving research efficiency. 

The global market for In-Vitro and In-Vivo Micro Electrode Arrays (MEAs) is witnessing significant growth due to the increasing focus on early cancer detection. Researchers and oncologists are exploring the integration of MEA technology with micro-needle arrays to monitor the electrical impedance of cancer tissue. This approach aims to study the electrical properties of various cancer cells and tissue cultures, offering potential for more accurate and patient-friendly cancer diagnosis. The market’s growth is driven by the high mortality rate of cancer and the need for advanced diagnostic tools. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

The In-vitro and In-vivo Micro Electrode Array (MEA) market is gaining significant traction in the biotech and pharmaceutical industries. MEAs, which include Micro Electrode Arrays and CMOS-based MEAs, play a crucial role in understanding neural activity and brain function for neurological disorders. In-vivo MEAs enable the recording of electrical signals from neurons in living organisms, while in-vitro MEAs are used for lab-grown neuronal networks. Challenges in this market include cancer tissue detection, biocompatibility, signal quality, and high-density electrodes. Technological advancements such as 3D nanoparticle printing, flexible electrodes, and graphene-based electrodes are addressing these challenges. Neurostimulation devices, drug development, disease modeling, and brain-computer interfaces are key applications for MEAs in clinical settings. CROs, government research labs, and Precision Instruments are major players in this market. Multiwell and single well MEAs, photolithography, and 3D printing are essential microfabrication techniques. Wireless recording technologies and personalized medicine are future growth areas.In-Vitro and In-Vivo Micro Electrode Arrays (MEAs) are widely used in research for studying neural activity. Advanced MEAs, such as in vitro CMO-based HDMEAs, are popular due to their capabilities. However, in vitro MEAs have limitations. They lack the high spatial resolution needed for stimulating and recording single cells, making them less suitable than dynamic clamp and patch clamp systems. Furthermore, MEA implantation, particularly chronic implantation, can result in biological responses like a decrease in functioning electrodes, glial scarring, and neuronal cell loss. These responses depend on factors such as MEA shank sizes, inter-shank distances, material composition, and implantation duration. Despite these challenges, MEAs remain a valuable tool for neuroscience research.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview

This in-vitro and in-vivo micro electrode array market report extensively covers market segmentation by

End-user 1.1 Pharmaceutical companies and CROs1.2 Academic/government and other research labsType 2.1 Multiwell MEA2.2 Single well MEAGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Pharmaceutical companies and CROs- The pharmaceutical and biotechnology industry and Contract Research Organizations (CROs) have increasingly adopted Micro Electrode Array (MEA) systems for neuroscience research. MEAs enable precise phenotypic drug screening while retaining neuronal functionality. CROs offer reduced costs and access to advanced equipment for pharmaceutical and biotechnology companies, making outsourcing an attractive option. MEAs are utilized for various research activities, from basic research to late-stage development, including genetic engineering, safety and efficacy tests, assay development, target validation, and clinical trials. Sanofi AG, Boehringer Ingelheim Pharma GmbH and Co. KG, and Janssen Pharmaceutica NV are among the companies employing MEAs for epilepsy research, cardiac safety assessment, and drug identification, respectively. The growing adoption of MEAs by these industry players is expected to fuel the expansion of the global in-vitro and in-vivo MEA market during the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

In-vitro Micro Electrode Arrays (MEAs), also known as Micro Electrode Arrays, are a valuable tool in various research fields, including neuroscience and cancer tissue detection. MEAs consist of an array of electrodes that can record electrical signals from living cells or tissues. Neuroscience researchers use MEAs to study neural activity, brain function, and neuroengineering. In the biotech and pharmaceutical industries, MEAs are employed for therapeutic solutions, such as neurostimulation devices. MEAs come in different formats, including Multiwell and Single well arrays. The latest advancements in MEA technology include CMOS-based MEAs and 3D nanoparticle printing. These innovations offer improved sensitivity, accuracy, and miniaturization, making MEAs an essential diagnostic and therapeutic solution for the future. In-Vitro Microelectrode Arrays provide valuable insights into electrical signals from living cells and tissues, contributing significantly to research and development in various industries.

Market Research Overview

In-vivo Micro Electrode Arrays (MEAs), also known as Micro Electrode Arrays for Neuroscience applications, are advanced technological tools used for recording neural activity and stimulating brain tissue in real-time. MEAs find extensive applications in various fields, including neurological disorders research, drug development, disease modeling, neuroengineering, and brain-computer interfaces. In-vivo MEAs can be fabricated using different materials such as CMOS, graphene, or flexible electrodes, using microfabrication techniques like photolithography and 3D printing. These arrays offer high-density electrodes, enabling the recording of electrical signals from a large number of neurons, neural networks, and synaptic connections. In vitro MEAs are used for diagnostic solutions, while in vivo MEAs are employed in therapeutic applications like neurostimulation devices, deep brain stimulation, and neural prosthetics. MEAs have significant potential in personalized medicine, allowing for the detection of drug candidates and monitoring brain function in clinical settings. Wireless recording technologies are also being explored to enhance the versatility of MEAs. In summary, MEAs play a crucial role in understanding brain function, developing new therapies, and advancing our knowledge of brain-related disorders.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userPharmaceutical Companies And CROsAcademic/government And Other Research LabsTypeMultiwell MEASingle Well MEAGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/in-vitro-and-in-vivo-micro-electrode-array-market-to-grow-by-usd-7-million-2024-2028-driven-by-mea-applications-in-neuroscience-research-with-ai-driving-market-transformation—technavio-302319761.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

DEKRA Korea to Acquire Global Product Service, Strengthening Consumer Electronics Testing and Certification Capabilities in Korea

Published

on

By

GIMHAE-SI, South Korea, April 20, 2026 /PRNewswire/ — DEKRA, a leading global provider of testing, inspection, and certification services, today announced it has signed a definitive agreement to acquire Global Product Service Co., Ltd (GPS), a prominent South Korean company renowned for its expertise in consumer electronics product testing and certification.

This strategic acquisition will significantly enhance DEKRA Korea’s capabilities within the rapidly growing consumer electronics sector, bringing together DEKRA’s global network and comprehensive service portfolio with GPS’s deep-rooted local knowledge and decades of experience serving South Korea’s leading manufacturers.

GPS has established a strong reputation for its in-depth technical expertise and unwavering commitment to quality, particularly within the consumer electronics market. For many years, GPS has been a trusted partner to major South Korean electronics companies, providing testing and certification services that ensure product safety, performance, and compliance with international standards.

The successful acquisition is a result of the strong collaboration and commitment from both DEKRA and GPS. Key representatives who participated in the signing, embodying this collaboration, were Dr. Kilian Aviles, Executive Vice President of DEKRA Group and Head of Asia Pacific Region; Ming Sheng, Vice President of Automotive Testing, DEKRA China; Young Seok Lee, CEO of Global Product Service Co., Ltd; and Seong Su Kim, Director of Global Product Service Co., Ltd.

“We are thrilled to welcome Global Product Service Co., Ltd to the DEKRA family,” said Dr. Kilian Aviles, Executive Vice President of DEKRA Group and Head of Asia Pacific Region. “This acquisition represents a significant milestone in our growth strategy in South Korea. GPS’s deep understanding of the local market, combined with their specialized expertise in consumer electronics, perfectly complements DEKRA’s global strengths. Together, we will offer unparalleled testing and certification solutions to our clients, empowering them to bring innovative and reliable products to market with greater speed and confidence.”

The integration of GPS into DEKRA Korea will leverage synergies in technology, talent, and market reach. This will enable DEKRA to further support South Korean manufacturers as they navigate complex global regulatory landscapes and strive for excellence in product development and quality assurance. Clients can expect a seamless transition and continued access to the high-quality services they have come to rely on from both organizations.

Young Seok Lee, CEO of Global Product Service Co., Ltd commented, “Joining forces with DEKRA is an exciting opportunity for GPS. DEKRA’s global reach and extensive resources will allow us to expand our service offerings and better serve our existing and future clients. We are confident that this partnership will create significant value for the South Korean consumer electronics industry, providing enhanced support and innovation.”

About DEKRA

For more than 100 years, DEKRA has been a trusted name in safety. Founded in 1925 with the original goal of improving road safety through vehicle inspections, DEKRA has grown to become the world’s largest independent, non-listed expert organization in the field of testing, inspection, and certification. Today, as a global partner, the company supports its customers with comprehensive services and solutions to drive safety and sustainability forward—fully aligned with DEKRA’s anniversary motto, “Securing the Future.” In 2024, DEKRA generated revenue of 4.3 billion euros. Around 48,000 employees are providing qualified and independent expert services in approximately 60 countries across five continents. DEKRA holds a Platinum rating from EcoVadis, placing it among the top 1% of the world’s most sustainable companies.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/dekra-korea-to-acquire-global-product-service-strengthening-consumer-electronics-testing-and-certification-capabilities-in-korea-302746801.html

SOURCE DEKRA Asia Pacific

Continue Reading

Technology

BLUETTI Showcases Integrated PAYGO Energy Solution at Canton Fair, Expanding Partnership Opportunities in Africa

Published

on

By

GUANGZHOU, China, April 20, 2026 /PRNewswire/ — From April 15-19, 2026, at the 139th Canton Fair, clean energy innovator BLUETTI presented an integrated Pay-As-You-Go (PAYGO) solution that combines digital distribution tools with off-grid energy products, as the company expands its presence in emerging markets, particularly across Africa.

The solution brings together BLUETTI’s proprietary BLUETTI GO platform and a range of PAYGO-enabled solar home systems, reflecting a broader shift in the industry from standalone hardware sales to more structured distribution and financing models.

PAYGO has gained traction in regions where upfront costs remain a key barrier to energy access. By enabling installment-based payments and remote device management, the model allows consumers to access electricity services with lower initial investment, while offering distributors greater visibility into repayment and asset performance.

BLUETTI GO serves as a centralized platform for distributors, integrating sales tracking, inventory control, credit profiling, payment overdue tracking, risk monitoring, and operational analysis. These features are designed to help partners operate more efficiently and support long-term business planning in PAYGO-driven markets.

The company’s product lineup includes entry-level solar home systems such as the P80(battery capacity 76.8Wh), to African Star (battery capacity 1728Wh), designed for basic electricity needs, as well as the higher-capacity Home Star (battery capacity 2kWh-5kWh) series for off-grid household energy storage. These systems can be deployed independently or bundled with appliances such as televisions, fans, and lighting equipment.

As demand for decentralized energy solutions grows across Africa, supported by both public and private investment in renewable infrastructure, PAYGO models are playing a larger role in bridging the gap between energy access and affordability. 

Driven by product breakthroughs and innovative business practices, BLUETTI has been enlarging its footprint in the region in recent years. The company operates across more than 40 African countries, supported by local teams and pilot programs, including a Nigerian initiative launched in 2020 that has expanded into a network of branded retail outlets.

About BLUETTI

Founded in 2013, BLUETTI is a leading global provider of energy storage solutions, specializing in home solar batteries, portable power stations, and solar generators. Through initiatives like the LAAF (Lighting Africa Affordable Financing program), BLUETTI aims to power 1 million African families in off-grid areas. Today, it serves over 3.5 million users in 140+ countries and regions. Learn more: https://bluetti.com/

Photo – https://mma.prnewswire.com/media/2960004/paygo_leads_______1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/bluetti-showcases-integrated-paygo-energy-solution-at-canton-fair-expanding-partnership-opportunities-in-africa-302746811.html

Continue Reading

Technology

Moomoo Pioneers the Era of Agentic Investing with Launch of Moomoo API Skills

Published

on

By

The first AI-powered API Skills that turn trading ideas into execution — no coding required

KUALA LUMPUR, Malaysia and SINGAPORE, April 15, 2026 /PRNewswire/ — Moomoo today announced the launch of Moomoo API Skills, its AI-powered capability that enables investors to execute sophisticated trading strategies using natural language — marking a major leap in making institutional-grade tools accessible to all.

This breakthrough positions Moomoo at the forefront of a new era of investing, where anyone with an idea can turn it into action — without writing a single line of code.

A First-of-Its-Kind Breakthrough in Investor Accessibility

For years, advanced trading capabilities such as algorithmic strategies, real-time automation, and multi-market data access have long been limited to professional traders.

Moomoo API Skills removes this barrier.

Investors can now describe their strategy in plain language, from technical signals to execution conditions, and have it translated into live or simulated trades instantly.

“This is the first time Wall Street-level trading capability is made truly accessible through everyday language,” said Robin Xu, Group Senior Partner & Senior Vice President, Futu Holdings. “We are not just simplifying trading tools — we are redefining who gets to use them.”

From Tools to Trading Assistants

Moomoo API Skills introduces a new paradigm of agentic investing, where AI acts as an execution partner rather than a passive tool.

Instead of navigating complex systems, investors can:

Describe their strategyLet AI translate it into execution logicMonitor and respond to markets in real time

This effectively creates an always on trading assistant, enabling faster and more structured decision making.

Institutional Capabilities Made Accessible

Built on Moomoo’s Open API ecosystem, the capability provides:

Zero code strategy executionGlobal market access across US, Singapore, Hong Kong SAR, Japan, and moreReal time monitoring and automated triggers

At the same time, Moomoo maintains strong control and security through its local-first architecture powered by Moomoo OpenD, where:

Data remains on the user’s local environmentExecution requires user confirmationExposure to third party risks is reduced

Closing the Execution Gap

Today’s investors are not short of information, but often face challenges in executing consistently and efficiently. Moomoo API Skills is designed to close this gap by simplifying how strategies are expressed and carried through. It also strengthens Moomoo’s ecosystem, including Moo Academy, MooveNetwork and the Option Playbook, enabling a seamless journey from learning to execution.

“The challenge today is no longer access to information, but the ability to act on it effectively,” said Xu.
“Moomoo API Skills helps investors translate intent into structured action while keeping them fully in control.”

Pioneering the Next Phase of Investing

The launch reflects a broader shift in investing, from tool based platforms to intent driven systems. With Moomoo API Skills, investors can define what they want to achieve, while intelligent systems handle how it is executed. This creates a more direct and structured path from idea to action, allowing investors to focus on strategy rather than operational complexity.

“We believe the next phase of investing is agentic — where investors define their intent and intelligent systems help carry out strategies. With Moomoo API Skills, investors can turn their ideas into structured strategies that can be tested and executed seamlessly within a single environment. Our focus is on enabling this in a way that enhances decision-making while keeping investors fully in control, bringing a more intuitive and accessible approach to strategy-driven investing,” said Xu.

About Moomoo

Moomoo is a leading global investment and trading platform dedicated to empowering investors with user-friendly tools, data, and insights. Our platform is designed to provide essential information and technology, enabling users to make well-informed investment decisions. With advanced charting tools, pro-level analytical features, Moomoo evolves alongside our users, fostering a dynamic community where investors can share, learn, and grow together.

Founded in the US, Moomoo has expanded its global presence to serve investors across multiple markets, including Singapore, Australia, Japan, Canada, Malaysia, and New Zealand. As a subsidiary of a Nasdaq-listed company, Moomoo is trusted by more than 29 million investors worldwide and has earned recognition from leading financial institutions and publications for its innovation and reliability.

For more information, please visit Moomoo’s official website at www.moomoo.com

Disclaimers

The contents herein do not constitute an offer, solicitation or recommendation to invest in any capital market products. Investors should understand the risks involved in relation to the products and services, conduct their own risk assessment and seek professional advice, where necessary. Investors should compare and consider the fee, charges and costs involved. Past performance is not indicative of future performance.

This document has not been reviewed by the Securities Commission Malaysia. Please refer to the Advertisement Disclaimer on our website.

Investments in capital market products involve risk. Full disclaimers at www.moomoo.com/sg/support/topic5_510. This advertisement has not been reviewed by the Monetary Authority of Singapore.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/moomoo-pioneers-the-era-of-agentic-investing-with-launch-of-moomoo-api-skills-302746815.html

SOURCE Moomoo

Continue Reading

Trending